ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 685860 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 685860; 2) Community: the network communities that were significantly associated with the response to NSC 685860; 3) Molecule: the relationships between components within communities and NSC 685860; 4) MDR: the compounds that were significantly associated with the NSC 685860.

NSC Compound Enrichment Correlation
NSC 83492 Null 0.0314734733353267 -0.17140993
NSC 686551 Null 0.0329129886465387 -0.010156795
NSC 732492 Null 0.0329129886465387 -0.084677083
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0329129886465387 -0.18497745
NSC 743695 Null 0.0329129886465387 0.1079847
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0329129886465387 -0.25578281
NSC 752344 Null 0.0329129886465387 -0.077727637
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0329129886465387 -0.19804113
NSC 405159 2,5-Cyclohexadiene-.delta.1,.alpha.-acetonitrile, 4-oxo-.alpha.-phenyl-, oxime 0.0329129886465389 -0.17247522
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.0329129886465389 0.21764363
Total:66  Current:48    [First] [Prev] [Next] [Last]